Naklofen (Diclofenac Sodium)

Diclofenac Sodium, the active ingredient in Naklofen, is a nonsteroidal anti-inflammatory drug presented as an injection for intramuscular use. It is employed to relieve pain and reduce inflammation associated with musculoskeletal conditions and postoperative recovery.

GNH USA supplies Naklofen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable logistics for global distribution, offering consistent batch release, regulatory documentation, and dedicated technical support.

Naklofen (diclofenac sodium) is indicated for conditions involving pain and inflammation within the musculoskeletal and postoperative domains.

- Pain relief: Provides analgesic effect to reduce acute and chronic pain. - Inflammation reduction: Decreases inflammatory response in affected tissues. - Musculoskeletal disorders: Alleviates pain and swelling in conditions such as sprains, strains, and arthritis. - Post‑operative pain: Controls pain and inflammation following surgical procedures.

Like other NSAIDs, diclofenac sodium may be associated with a range of adverse reactions.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Injection site reactions: erythema, swelling, or pain at the administration site.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Renal impairment: reduced kidney function or acute renal failure. - Cardiovascular events: increased risk of myocardial infarction or stroke.

When using Naklofen, several safety considerations should be observed to minimize risk.

- Assess renal function: avoid use in patients with severe renal impairment. - Monitor hepatic status: caution in individuals with liver disease. - Evaluate cardiovascular risk: use cautiously in patients with history of heart disease. - Avoid concurrent NSAIDs: increase risk of gastrointestinal bleeding. - Pregnancy and lactation: contraindicated unless clearly needed; consult obstetrician. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Diclofenac sodium can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): increased gastrointestinal bleeding. - ACE inhibitors or ARBs: may reduce renal perfusion and cause kidney injury.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced diuretic effect and renal function changes. - Lithium: risk of increased lithium levels and toxicity. - Methotrexate: possible decreased clearance leading to toxicity.